Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can targeted muscle techniques outperform standard therapy for piriformis pain?

NCT ID NCT07769203

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 17, 2026 · Last updated Aug 18, 2026 · Updated 1 time

Summary

This study tests whether two hands-on therapies—muscle energy technique and myofascial release—can improve pain, muscle strength, and activation in people with piriformis syndrome, a condition where a deep buttock muscle irritates the sciatic nerve. About 72 adults aged 18–65 with the condition will receive one of the techniques alongside conventional physical therapy for 8 weeks. Researchers will use objective tools like pressure sensors and electromyography to measure changes, aiming to identify which approach offers better relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Muscle Energy Technique and Myofascial Release Technique (manual therapy procedures)
What this could lead to
If one technique proves more effective, it could become a preferred non-drug treatment for piriformis syndrome, offering better pain relief and muscle function.
What could go wrong
This is a small, early-stage trial, so results may not apply to everyone. Manual therapy effects can vary, and the study doesn't compare against a placebo, so benefits might be partly due to attention or expectation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 72 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals diagnosed with piriformis syndrome * Presence of piriformis tenderness and sciatic symptoms * Aged between 18 and 65 years * Voluntary agreement to participate in the study * No history of lumbar, hip, knee, or ankle surgery within the last year * Ability to cooperate with the assessment and treatment procedures Exclusion Criteria: * Individuals younger than 18 years or older than 65 years * Presence of any musculoskeletal disorder affecting the lower extremity * Presence of neurological, cardiac, pulmonary, or orthopedic disorders preventing participation in exercise * Presence of neurological deficits (muscle strength loss) * History of radiotherapy to the lumbar or hip region * Absence from more than 20% of treatment sessions * Inability to comply with the study procedures (e.g., cognitive impairment, communication problems, severe psychiatric disorders) * Corticosteroid or PRP injection within the last 3 months * Participation in another physical therapy program within the last 3 months * Use of analgesic, anti-inflammatory, or muscle relaxant medications within the last 48-72 hours * Use of psychotropic medications that may affect muscle activation or nervous system responses (e.g., antidepressants, antipsychotics, sedatives)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Piriformis syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hasan Kalyoncu University Faculty of Health Sciences

    Gaziantep, Şehitkamil, 27000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.